Skip to main content

Artificial pancreas systems


05-24-2017 | Artificial pancreas systems | News

Meta-analysis supports artificial pancreas superiority over pumps

Artificial pancreas systems increase time in blood glucose target range by nearly 3 hours per day compared with conventional pump therapy in outpatients with type 1 diabetes, meta-analysis data show.

01-16-2017 | Artificial pancreas systems | News

Artificial pancreas benefits even well-controlled diabetes

Results of a randomized crossover trial show that closed-loop insulin delivery offers significantly improved glycemic control even in patients who are well controlled when self-monitoring their glucose levels.

12-21-2016 | Artificial pancreas systems | News

Bihormonal artificial pancreas offers good glycemic control

Results of a randomized crossover trial suggest that a bihormonal artificial pancreas that can be used at home and is initialized only with body mass index provides good glycemic control among adults with type 1 diabetes.

Read more

Related topics



In depth

03-21-2017 | Adolescents | Feature | Article

Adolescents: A challenging age group

Professor Moshe Phillip tells medwireNews why he believes the artificial pancreas will be of particular benefit for adolescents and young adults with type 1 diabetes.

03-03-2017 | Artificial pancreas systems | Hot topic review | Article

The artificial pancreas: Potential to transform diabetes care

medwireNews provides an overview of artificial pancreas systems, and talks to Professor Richard Bergenstal about their potential for treating type 1 diabetes.

Journal articles and book chapters

01-23-2017 | Type 1 diabetes | Review | Article

Closed-loop for type 1 diabetes – an introduction and appraisal for the generalist

Rapid progress over the past decade has been made with the development of the ‘Artificial Pancreas’, or closed-loop system. The recent FDA approval of the first hybrid closed-loop system makes the Artificial Pancreas a realistic therapeutic option for people with type 1 diabetes. In anticipation of its advent into clinical care, the authors provide a primer and appraisal of this novel therapeutic approach in type 1 diabetes for healthcare professionals and non-specialists in the field.

Bally L, Thabit H, & Hovorka R. BMC Med 2017;15:14. doi:10.1186/s12916-017-0794-8

09-01-2016 | Devices and technology | Review | Article

Coming of age: The artificial pancreas for type 1 diabetes

A review on the progress being made in the development and evaluation of closed-loop systems in outpatient settings.

Heinemann L et al. Diabetologia 2015;58:862–870. doi:10.1007/s00125-015-3513-z

image credits